Novartis gets EU nod for kidney tumor drug Votubia
www.reuters.com | 05.11.2012.
ZURICH (Reuters) - Novartis said on Monday its drug Votubia had received approval from the European Commission for treating non-cancerous kidney tumors in patients with a rare genetic disease known as tuberous sclerosis complex (TSC).
br />
This marks the first approval of a medical treatment in this patient population in Europe, Novartis said.
